Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina

Although adeno-associated viral (AAV) vector-mediated retinal gene therapies have demonstrated efficacy, the mechanisms underlying dose-dependent retinal inflammation remain poorly understood. Here we present a quantitative analysis of cellular immune response to subretinal AAV gene therapy in mice...

Full description

Bibliographic Details
Main Authors: Chandler, LC, McClements, ME, Yusuf, IH, Martinez-Fernandez de la Camara, C, MacLaren, RE, Xue, K
Format: Journal article
Language:English
Published: Cell Press 2021
_version_ 1826277081805225984
author Chandler, LC
McClements, ME
Yusuf, IH
Martinez-Fernandez de la Camara, C
MacLaren, RE
Xue, K
author_facet Chandler, LC
McClements, ME
Yusuf, IH
Martinez-Fernandez de la Camara, C
MacLaren, RE
Xue, K
author_sort Chandler, LC
collection OXFORD
description Although adeno-associated viral (AAV) vector-mediated retinal gene therapies have demonstrated efficacy, the mechanisms underlying dose-dependent retinal inflammation remain poorly understood. Here we present a quantitative analysis of cellular immune response to subretinal AAV gene therapy in mice using multicolor flow cytometry with a panel of key immune cell markers. A significant increase in CD45+ retinal leukocytes was detected from day 14 post-subretinal injection of an AAV8 vector (1x109 genome copies) encoding green fluorescent protein (GFP) driven by a ubiquitous promoter. These predominantly consisted of infiltrating peripheral leukocytes including macrophages, natural killer cells, CD4 and CD8 T cells, and natural killer T cells, no significant change in resident microglia population was detected. This cellular response was persistent at 28 days and suggestive of type 1 cell-mediated effector immunity. High levels (∼80%) of GFP fluorescence were found in the microglia, implicating their role in viral antigen presentation and peripheral leukocyte recruitment. When compared against AAV.GFP in paired eyes, an equivalent dose of an otherwise identical vector encoding the human therapeutic transgene Rab-escort protein 1 (REP1) elicited a significantly diminished cellular immune response (4.2-fold; p=0.0221). However, the distribution of immune cell populations remained similar, indicating a common mechanism of AAV-induced immune activation.
first_indexed 2024-03-06T23:23:32Z
format Journal article
id oxford-uuid:6998afe6-9ac3-41fb-a0d4-c0da0926b107
institution University of Oxford
language English
last_indexed 2024-03-06T23:23:32Z
publishDate 2021
publisher Cell Press
record_format dspace
spelling oxford-uuid:6998afe6-9ac3-41fb-a0d4-c0da0926b1072022-03-26T18:51:58ZCharacterizing the cellular immune response to subretinal AAV gene therapy in the murine retinaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6998afe6-9ac3-41fb-a0d4-c0da0926b107EnglishSymplectic ElementsCell Press2021Chandler, LCMcClements, MEYusuf, IHMartinez-Fernandez de la Camara, CMacLaren, REXue, KAlthough adeno-associated viral (AAV) vector-mediated retinal gene therapies have demonstrated efficacy, the mechanisms underlying dose-dependent retinal inflammation remain poorly understood. Here we present a quantitative analysis of cellular immune response to subretinal AAV gene therapy in mice using multicolor flow cytometry with a panel of key immune cell markers. A significant increase in CD45+ retinal leukocytes was detected from day 14 post-subretinal injection of an AAV8 vector (1x109 genome copies) encoding green fluorescent protein (GFP) driven by a ubiquitous promoter. These predominantly consisted of infiltrating peripheral leukocytes including macrophages, natural killer cells, CD4 and CD8 T cells, and natural killer T cells, no significant change in resident microglia population was detected. This cellular response was persistent at 28 days and suggestive of type 1 cell-mediated effector immunity. High levels (∼80%) of GFP fluorescence were found in the microglia, implicating their role in viral antigen presentation and peripheral leukocyte recruitment. When compared against AAV.GFP in paired eyes, an equivalent dose of an otherwise identical vector encoding the human therapeutic transgene Rab-escort protein 1 (REP1) elicited a significantly diminished cellular immune response (4.2-fold; p=0.0221). However, the distribution of immune cell populations remained similar, indicating a common mechanism of AAV-induced immune activation.
spellingShingle Chandler, LC
McClements, ME
Yusuf, IH
Martinez-Fernandez de la Camara, C
MacLaren, RE
Xue, K
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title_full Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title_fullStr Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title_full_unstemmed Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title_short Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
title_sort characterizing the cellular immune response to subretinal aav gene therapy in the murine retina
work_keys_str_mv AT chandlerlc characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina
AT mcclementsme characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina
AT yusufih characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina
AT martinezfernandezdelacamarac characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina
AT maclarenre characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina
AT xuek characterizingthecellularimmuneresponsetosubretinalaavgenetherapyinthemurineretina